Fruit Fly Gives Hint of Parkinson's Cause
Posted on: Wednesday, 31 January 2007, 18:01 CST
U.S. researchers said Wednesday studies with fruit flies indicate that a mutated gene kills dopamine cells, resulting in Parkinson's disease.
In humans, a lack of the neurotransmitter dopamine has long been known to play a role in Parkinson's disease. It is also known that mutations in a protein called parkin cause a form of Parkinson's that is inherited.
We put the mutant parkin in all different kinds of tissues and in different kinds of neurons, and it was toxic only to the ones that used dopamine, said George Jackson, associate professor of neurology and senior scientist at the Semel Institute for Neuroscience and Human Behavior at the University of California-Los Angeles.
Jackson, reporting in Wednesday's issue of the Journal of Neuroscience, said that genetically engineering the simple Drosophila (fruit fly) with the mutated parkin gene resulted in Parkinson's-like motor dysfunction in the fly.
Thus, the interaction of mutant parkin with dopamine may be key to understanding the cause of the inherited form of Parkinson's disease.
Having a genetic model of Parkinson's disease in the fruit fly will allow researchers to run mass testing, or screens, of genes in order to find the novel pathways -- networks of interacting proteins that carry out biological functions -- that control survival of those dopamine-generating neurons.
Since a lot of those pathways regulating cell survival and death are conserved by evolution all the way from flies to humans, said Jackson, if we find those genes in the fly, they may represent new therapeutic targets for Parkinson's disease in humans.
Source: United Press International
Related Articles
- AMT Obtains License to Amgen's GDNF Gene to Develop Treatment for Parkinson's Disease With AMT's Proprietary Gene Therapy Platform
- U.S. FDA Approves Requip(R) XL(TM), the First and Only Oral Once-Daily Non-Ergot Dopamine Agonist for Parkinson's Disease
- Anti-Alzheimer's Disease Drugs (Cholinesterase Inhibitors, and NMDARA), and Anti-Parkinson's Disease Drugs (Dopaminergic Agents, and Dopamine Agonists) Are Classified Inside 2006 Global Strategic Business Report
- FoldRx Announces Study Defining Role of Key Protein and Biological Pathway Implicated in Parkinson's Disease; Collaborators' Research in Science Points Way to New Treatment Approaches and Validates Company's Discovery Engine
- Avigen Announces Encouraging Early Data From Parkinson's Disease Clinical Trial
- Pramipexole, Ropinirole, and Mania in Parkinson's Disease
- Striatal Dopamine Transporter Imaging Correlates With Anxiety and Depression Symptoms in Parkinson's Disease
- CLINICAL REVIEW: The Treatment of Parkinson's Disease
- Avigen's AV201 for Parkinson's Disease Begins Clinical Trials
- AGILECT(R) Improved Parkinson's Disease Symptoms Without Worsening Cognitive and Behavioral Symptoms
User Comments (0)

RSS Feeds